It has been shown that curcumin inhibits mammalian target of rapamycin (mTOR)—a serin/threonine kinase—and downregulates the key epigenetic regulator enhancer of zeste homolog 2 (EZH2) in tamoxifen resistant breast cancer cells [236]. This evidence concerns the gene EZH2 and breast carcinoma.